Boussard & Gavaudan Asset Management
Latest statistics and disclosures from Boussard & Gavaudan Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are 0 0, and represent % of Boussard & Gavaudan Asset Management's stock portfolio.
- Added to shares of these 1 stock: 0 0.
- Started 1 new stock position in 0 0.
- Reduced shares in these 10 stocks: , Mead Johnson Nutrition (-$59M), QCOM (-$48M), CRTO (-$11M), Reynolds American (-$8.7M), INTC (-$5.2M), EWZ, DFS, Mylan, .
- Sold out of its positions in Adt, Aetna, A, ALK, ALL, AMP, AIZ, AZO, AVY, BALL.
- Boussard & Gavaudan Asset Management was a net seller of stock by $-238M.
- Central Index Key (CIK): 0001598175
Portfolio Holdings for Boussard & Gavaudan Asset Management
Boussard & Gavaudan Asset Management holds 1 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| 0 0 | 0.0 | $0 | NEW | 0 | 0.00 |
|
Past Filings by Boussard & Gavaudan Asset Management
SEC 13F filings are viewable for Boussard & Gavaudan Asset Management going back to 2013
- Boussard & Gavaudan Asset Management 2014 Q3 filed Nov. 5, 2014
- Boussard & Gavaudan Asset Management 2014 Q2 filed Aug. 1, 2014
- Boussard & Gavaudan Asset Management 2014 Q1 filed April 28, 2014
- Boussard & Gavaudan Asset Management 2013 Q4 filed Feb. 3, 2014